Clinical Trials Browser

cc-486 × Gastrointestinal × Clear all

Pancreatic Neoplasms

NCT02811497 2021-04-01

METADUR

Phase 2 Completed

28 enrolled

BreastGastrointestinalGynecologic

Microsatellite Stable Colorectal Carcinoma

NCT01478685 2019-11-12

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Phase 1 Completed

169 enrolled

GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence, Tumor Virus Infections, Carcinoma, Pancreatic Ductal

Clinical Trials

Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)

METADUR

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors